Mark D. Savellano

574 total citations
14 papers, 492 citations indexed

About

Mark D. Savellano is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark D. Savellano has authored 14 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Biomedical Engineering and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark D. Savellano's work include Photodynamic Therapy Research Studies (9 papers), Nanoplatforms for cancer theranostics (6 papers) and Immunotherapy and Immune Responses (3 papers). Mark D. Savellano is often cited by papers focused on Photodynamic Therapy Research Studies (9 papers), Nanoplatforms for cancer theranostics (6 papers) and Immunotherapy and Immune Responses (3 papers). Mark D. Savellano collaborates with scholars based in United States, United Kingdom and Norway. Mark D. Savellano's co-authors include Tayyaba Hasan, Brian W. Pogue, P. Jack Hoopes, Keith D. Paulsen, Ellen S. Vitetta, Summer L. Gibbs, Bin Chen, Alexei Bogdanov, Anne C.E. Moor and Pål Kristian Selbo and has published in prestigious journals such as Applied Physics Letters, Cancer Research and Clinical Cancer Research.

In The Last Decade

Mark D. Savellano

14 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Savellano United States 11 339 333 91 79 68 14 492
Ray R. Zhang United States 11 352 1.0× 190 0.6× 135 1.5× 135 1.7× 160 2.4× 17 706
Daniel R. Draney United States 8 249 0.7× 117 0.4× 95 1.0× 79 1.0× 141 2.1× 13 477
Е. В. Филоненко Russia 13 363 1.1× 467 1.4× 39 0.4× 147 1.9× 65 1.0× 110 632
Hidetoshi Honda Japan 12 464 1.4× 714 2.1× 101 1.1× 117 1.5× 76 1.1× 19 895
Jiaqi Huang China 13 453 1.3× 196 0.6× 52 0.6× 146 1.8× 171 2.5× 45 672
Toshiko Harada United States 15 497 1.5× 496 1.5× 100 1.1× 82 1.0× 159 2.3× 20 808
Martyna Krzykawska-Serda Poland 12 254 0.7× 151 0.5× 88 1.0× 161 2.0× 92 1.4× 30 512
W S Chan United Kingdom 14 322 0.9× 449 1.3× 30 0.3× 262 3.3× 141 2.1× 16 617
Rainer Kühnlein Germany 7 256 0.8× 89 0.3× 68 0.7× 47 0.6× 121 1.8× 9 462
Nicholas Bernards Canada 13 163 0.5× 113 0.3× 75 0.8× 47 0.6× 147 2.2× 36 489

Countries citing papers authored by Mark D. Savellano

Since Specialization
Citations

This map shows the geographic impact of Mark D. Savellano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Savellano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Savellano more than expected).

Fields of papers citing papers by Mark D. Savellano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Savellano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Savellano. The network helps show where Mark D. Savellano may publish in the future.

Co-authorship network of co-authors of Mark D. Savellano

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Savellano. A scholar is included among the top collaborators of Mark D. Savellano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Savellano. Mark D. Savellano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Savellano, Mark D., et al.. (2012). Photodynamic Tumor Eradication With a Novel Targetable Photosensitizer: Strong Vascular Effects and Dependence on Treatment Repetition Versus Potentiation. Photochemistry and Photobiology. 89(3). 687–697. 9 indexed citations
2.
Abu‐Yousif, Adnan O., Anne C.E. Moor, Xiang Zheng, et al.. (2012). Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells. Cancer Letters. 321(2). 120–127. 63 indexed citations
3.
Savellano, Mark D., et al.. (2010). Development of an ErbB‐overexpressing A‐431 Optical Reporting Tumor Xenograft Model to Assess Targeted Photodynamic Therapy Regimens. Photochemistry and Photobiology. 86(6). 1379–1389. 2 indexed citations
4.
Chen, Bin, Chong He, David Gondek, et al.. (2008). Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin‐mediated vascular‐targeting therapy. International Journal of Cancer. 123(3). 695–701. 42 indexed citations
5.
Hoopes, P. Jack, Ursula J. Gibson, Q. Zeng, et al.. (2007). Intratumoral iron oxide nanoparticle hyperthermia and radiation cancer treatment. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 6440. 64400K–64400K. 13 indexed citations
6.
Savellano, Mark D. & Tayyaba Hasan. (2005). Photochemical Targeting of Epidermal Growth Factor Receptor: A Mechanistic Study. Clinical Cancer Research. 11(4). 1658–1668. 81 indexed citations
7.
Savellano, Mark D., Brian W. Pogue, P. Jack Hoopes, Ellen S. Vitetta, & Keith D. Paulsen. (2005). Multiepitope HER2 Targeting Enhances Photoimmunotherapy of HER2-Overexpressing Cancer Cells with Pyropheophorbide-a Immunoconjugates. Cancer Research. 65(14). 6371–6379. 70 indexed citations
8.
Savellano, Mark D., et al.. (2004). Measurement of tumor interstitial volume fraction: Method and implication for drug delivery. Magnetic Resonance in Medicine. 52(3). 485–494. 29 indexed citations
9.
Pogue, Brian W., Summer L. Gibbs, Bin Chen, & Mark D. Savellano. (2004). Fluorescence Imaging in Vivo: Raster Scanned Point-Source Imaging Provides More Accurate Quantification than Broad Beam Geometries. Technology in Cancer Research & Treatment. 3(1). 15–21. 51 indexed citations
10.
Savellano, Mark D., et al.. (2003). Targeting Cells That Overexpress the Epidermal Growth Factor Receptor with Polyethylene Glycolated BPD Verteporfin Photosensitizer Immunoconjugates. 21 indexed citations
11.
Savellano, Mark D. & Tayyaba Hasan. (2003). Targeting Cells That Overexpress the Epidermal Growth Factor Receptor with Polyethylene Glycolated BPD Verteporfin Photosensitizer Immunoconjugates ¶. Photochemistry and Photobiology. 77(4). 431–431. 85 indexed citations
12.
Kim, Young Ro, Mark D. Savellano, Ralph Weissleder, & Alexei Bogdanov. (2002). Steady-state and Dynamic Contrast MR Imaging of Human Prostate Cancer Xenograft Tumors: A Comparative Study. Technology in Cancer Research & Treatment. 1(6). 489–495. 12 indexed citations
13.
He, Gang, Mark D. Savellano, & Harry A. Atwater. (1994). Synthesis of dislocation free Siy(SnxC1−x)1−y alloys by molecular beam deposition and solid phase epitaxy. Applied Physics Letters. 65(9). 1159–1161. 11 indexed citations
14.
He, Gang, Mark D. Savellano, & Harry A. Atwater. (1993). Synthesis of Dislocation Free Siy(SnxC1−x)1−y Alloys by Molecular Beam Deposition and Solid Phase Epitaxy. MRS Proceedings. 298. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026